(-)-demecolcine increases expression ISO RGD:68499 6480464 Demecolcine results in increased expression of NR5A2 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO RGD:68500 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NR5A2 mRNA CTD PMID:36331819 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,2-dilauroyl-sn-glycero-3-phosphocholine(1+) increases expression ISO RGD:68500 6480464 1, 2-dilauroylphosphatidylcholine results in increased expression of NR5A2 CTD PMID:24459144 1-O-oleoyl-sn-glycero-3-phosphocholine multiple interactions ISO RGD:68500 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of 1-oleoyl lysophosphatidylcholine CTD PMID:29515023 17alpha-ethynylestradiol increases expression ISO RGD:68500 6480464 Ethinyl Estradiol results in increased expression of NR5A2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:68500 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of NR5A2 mRNA CTD PMID:15834898 17beta-estradiol increases expression ISO RGD:68499 6480464 Estradiol results in increased expression of NR5A2 mRNA CTD PMID:20607599 more ... 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA CTD PMID:32741896 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of NR5A2 mRNA CTD PMID:32145629 17beta-estradiol decreases abundance ISO RGD:68500 6480464 NR5A2 protein results in decreased abundance of Estradiol CTD PMID:18628394 17beta-estradiol multiple interactions ISO RGD:68500 6480464 [[NR5A2 protein results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in decreased activity of CYP19A1 protein] which results in decreased chemical synthesis of Estradiol, [NR5A2 results in increased expression of NOS3 mRNA] which results in decreased abundance of Estradiol CTD PMID:18628394 17beta-estradiol decreases expression ISO RGD:68499 6480464 Estradiol results in decreased expression of NR5A2 mRNA CTD PMID:20106945 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:68500 6480464 Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68499 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide affects the reaction [Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA] CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68500 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA CTD PMID:29452137 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68500 6480464 Tetrachlorodibenzodioxin affects the expression of NR5A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68500 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A2 mRNA more ... CTD PMID:17942748 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:68499 6480464 Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA CTD PMID:20106945 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68499 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA CTD PMID:17517823 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-methoxyethanol multiple interactions EXP 6480464 Bromocriptine affects the reaction [methyl cellosolve results in increased expression of NR5A2 mRNA] CTD PMID:21427058 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of NR5A2 mRNA CTD PMID:21427058 4,4'-diaminodiphenylmethane decreases expression ISO RGD:68500 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of NR5A2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:68499 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene CTD PMID:31601247 5-fluorouracil affects expression ISO RGD:68500 6480464 Fluorouracil affects the expression of NR5A2 protein CTD PMID:21296659 9-cis-retinoic acid decreases expression ISO RGD:68499 6480464 Alitretinoin results in decreased expression of NR5A2 mRNA CTD PMID:16357189 9-cis-retinoic acid multiple interactions ISO RGD:68499 6480464 Alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]], Alitretinoin inhibits the reaction [NR5A2 protein results in increased expression of CYP19A1 mRNA] CTD PMID:16357189 acetic acid decreases expression ISO RGD:68500 6480464 Acetic Acid results in decreased expression of NR5A2 protein CTD PMID:21296659 aflatoxin B1 affects expression ISO RGD:68499 6480464 Aflatoxin B1 affects the expression of NR5A2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:68499 6480464 Aflatoxin B1 results in increased methylation of NR5A2 intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:68499 6480464 Aflatoxin B1 results in decreased methylation of NR5A2 gene CTD PMID:27153756 aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of NR5A2 mRNA CTD PMID:25450479 Aflatoxin B2 alpha decreases methylation ISO RGD:68499 6480464 aflatoxin B2 results in decreased methylation of NR5A2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:68499 6480464 Tretinoin results in increased expression of NR5A2 mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NR5A2 mRNA CTD PMID:16483693 androst-4-ene-3,17-dione increases expression EXP 6480464 Androstenedione results in increased expression of NR5A2 mRNA CTD PMID:21273442 androst-4-ene-3,17-dione multiple interactions EXP 6480464 AR mutant form inhibits the reaction [Androstenedione results in increased expression of NR5A2 mRNA] CTD PMID:21273442 arachidonic acid multiple interactions ISO RGD:68500 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in decreased abundance of Arachidonic Acid analog CTD PMID:29515023 arachidonic acid decreases chemical synthesis ISO RGD:68500 6480464 NR5A2 gene mutant form results in decreased chemical synthesis of Arachidonic Acid CTD PMID:29515023 arsane affects methylation ISO RGD:68499 6480464 Arsenic affects the methylation of NR5A2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:68499 6480464 Arsenic affects the methylation of NR5A2 gene CTD PMID:25304211 arsenite(3-) increases methylation ISO RGD:68499 6480464 arsenite results in increased methylation of NR5A2 promoter CTD PMID:23974009 arsenite(3-) decreases expression ISO RGD:68499 6480464 arsenite results in decreased expression of NR5A2 mRNA CTD PMID:31646340 atrazine increases activity ISO RGD:68499 6480464 Atrazine results in increased activity of NR5A2 protein CTD PMID:18461179 aztreonam increases expression ISO RGD:68500 6480464 Aztreonam results in increased expression of NR5A2 mRNA CTD PMID:24657338 benzo[a]pyrene affects methylation ISO RGD:68499 6480464 Benzo(a)pyrene affects the methylation of NR5A2 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:68499 6480464 Benzo(a)pyrene results in decreased expression of NR5A2 mRNA CTD PMID:32234424 benzo[e]pyrene decreases methylation ISO RGD:68499 6480464 benzo(e)pyrene results in decreased methylation of NR5A2 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:68500 6480464 Diethylhexyl Phthalate results in decreased expression of NR5A2 mRNA CTD PMID:25975992 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of NR5A2 mRNA CTD PMID:29945229 bisphenol A increases expression ISO RGD:68500 6480464 bisphenol A results in increased expression of NR5A2 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A multiple interactions ISO RGD:68499 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NR5A2 mRNA CTD PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NR5A2 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A affects methylation ISO RGD:68500 6480464 bisphenol A affects the methylation of NR5A2 promoter CTD PMID:27334623 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NR5A2 gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NR5A2 mRNA CTD PMID:25181051 , PMID:32145629 bromochloroacetic acid increases expression ISO RGD:68500 6480464 bromochloroacetic acid results in increased expression of NR5A2 protein CTD PMID:21296659 bromocriptine multiple interactions EXP 6480464 Bromocriptine affects the reaction [methyl cellosolve results in increased expression of NR5A2 mRNA] CTD PMID:21427058 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of NR5A2 mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:68499 6480464 Cadmium results in increased expression of NR5A2 mRNA CTD PMID:31646340 carbon nanotube decreases expression ISO RGD:68500 6480464 Nanotubes more ... CTD PMID:25620056 cefalotin multiple interactions ISO RGD:68500 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA CTD PMID:24657338 cholesterol affects abundance ISO RGD:68500 6480464 NR5A2 gene mutant form affects the abundance of Cholesterol CTD PMID:29515023 choline multiple interactions ISO RGD:68500 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of NR5A2, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR5A2 gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:68499 6480464 Cisplatin results in decreased expression of NR5A2 mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:68500 6480464 Clofibrate results in increased expression of NR5A2 mRNA CTD PMID:28973556 cobalt dichloride decreases expression ISO RGD:68499 6480464 cobaltous chloride results in decreased expression of NR5A2 mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of NR5A2 mRNA CTD PMID:24386269 colforsin daropate hydrochloride multiple interactions ISO RGD:68499 6480464 alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]], NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] CTD PMID:16357189 colforsin daropate hydrochloride increases expression ISO RGD:68499 6480464 Colforsin results in increased expression of NR5A2 mRNA CTD PMID:16357189 crocidolite asbestos increases methylation ISO RGD:68499 6480464 Asbestos, Crocidolite results in increased methylation of NR5A2 gene CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:68499 6480464 Cyclosporine results in decreased expression of NR5A2 mRNA CTD PMID:20106945 , PMID:27989131 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of NR5A2 mRNA CTD PMID:20888898 dextran sulfate multiple interactions ISO RGD:68500 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR5A2 mRNA CTD PMID:29950665 dibenz[a,h]anthracene increases expression ISO RGD:68500 6480464 1 more ... CTD PMID:26377693 diethylstilbestrol increases expression ISO RGD:68500 6480464 Diethylstilbestrol results in increased expression of NR5A2 mRNA CTD PMID:22100434 Diosbulbin B decreases expression ISO RGD:68500 6480464 diosbulbin B results in decreased expression of NR5A2 mRNA CTD PMID:32148032 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NR5A2 mRNA CTD PMID:33729688 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of NR5A2 mRNA CTD PMID:29391264 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NR5A2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:68500 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of NR5A2, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR5A2 gene CTD PMID:20938992 formaldehyde increases expression ISO RGD:68499 6480464 Formaldehyde results in increased expression of NR5A2 mRNA CTD PMID:23649840 fulvestrant increases expression ISO RGD:68499 6480464 Fulvestrant results in increased expression of NR5A2 mRNA CTD PMID:31646340 fulvestrant multiple interactions ISO RGD:68499 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene, [bisphenol A co-treated with Fulvestrant] results in decreased methylation of NR5A2 gene CTD PMID:31601247 genistein increases expression ISO RGD:68500 6480464 Genistein results in increased expression of NR5A2 mRNA CTD PMID:22553218 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NR5A2 mRNA CTD PMID:33387578 imipenem hydrate multiple interactions ISO RGD:68500 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA CTD PMID:24657338 L-methionine multiple interactions ISO RGD:68500 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of NR5A2, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NR5A2 gene CTD PMID:20938992 lead nitrate increases expression ISO RGD:68500 6480464 lead nitrate results in increased expression of NR5A2 mRNA CTD PMID:16049268 linoleic acid multiple interactions ISO RGD:68500 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Linoleic Acid analog CTD PMID:29515023 lipopolysaccharide multiple interactions ISO RGD:68499 6480464 [S-(1 more ... CTD PMID:35811015 lithocholic acid decreases expression EXP 6480464 Lithocholic Acid results in decreased expression of NR5A2 mRNA CTD PMID:20888898 lysophosphatidylcholine multiple interactions ISO RGD:68500 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Lysophosphatidylcholines CTD PMID:29515023 lysophosphatidylethanolamine multiple interactions ISO RGD:68500 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of lysophosphatidylethanolamine, [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of lysophosphatidylethanolamine analog CTD PMID:29515023 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of NR5A2 mRNA CTD PMID:30467583 methapyrilene decreases methylation ISO RGD:68499 6480464 Methapyrilene results in decreased methylation of NR5A2 intron CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:68499 6480464 methylmercuric chloride results in increased expression of NR5A2 mRNA CTD PMID:23903816 N-methyl-4-phenylpyridinium decreases expression ISO RGD:68499 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of NR5A2 mRNA CTD PMID:24810058 N-nitrosodiethylamine multiple interactions EXP 6480464 bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of NR5A2 mRNA] CTD PMID:17106253 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of NR5A2 mRNA CTD PMID:17106253 neomycin multiple interactions ISO RGD:68500 6480464 [Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA CTD PMID:24657338 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of NR5A2 mRNA CTD PMID:26720608 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of NR5A2 mRNA CTD PMID:33484710 obeticholic acid decreases expression ISO RGD:68499 6480464 obeticholic acid results in decreased expression of NR5A2 mRNA CTD PMID:27939613 ozone decreases expression ISO RGD:68500 6480464 Ozone results in decreased expression of NR5A2 mRNA CTD PMID:16183385 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of NR5A2 mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:68500 6480464 Acetaminophen results in decreased expression of NR5A2 mRNA CTD PMID:17585979 paracetamol multiple interactions ISO RGD:68500 6480464 YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of NR5A2 mRNA] CTD PMID:34546377 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NR5A2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:68499 6480464 Acetaminophen results in decreased expression of NR5A2 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:68500 6480464 Acetaminophen affects the expression of NR5A2 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:68500 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NR5A2 mRNA CTD PMID:36331819 phenobarbital multiple interactions ISO RGD:68500 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NR5A2 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:68500 6480464 Phenobarbital affects the expression of NR5A2 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:68500 6480464 Phenobarbital results in increased expression of NR5A2 mRNA CTD PMID:19482888 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:68499 6480464 alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]], NR5A2 protein promotes the reaction [[Colforsin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] CTD PMID:16357189 phosphatidylcholine multiple interactions ISO RGD:68500 6480464 [NR5A2 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased abundance of Phosphatidylcholines CTD PMID:29515023 pirinixic acid decreases expression ISO RGD:68500 6480464 pirinixic acid results in decreased expression of NR5A2 mRNA CTD PMID:18445702 potassium dichromate decreases expression ISO RGD:68500 6480464 Potassium Dichromate results in decreased expression of NR5A2 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of NR5A2 mRNA CTD PMID:20888898 progesterone decreases abundance ISO RGD:68500 6480464 NR5A2 gene mutant form results in decreased abundance of Progesterone CTD PMID:17409375 progesterone increases abundance ISO RGD:68500 6480464 NR5A2 protein results in increased abundance of Progesterone CTD PMID:18628394 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68499 6480464 [S-(1 more ... CTD PMID:35811015 sodium arsenite decreases expression ISO RGD:68499 6480464 sodium arsenite results in decreased expression of NR5A2 mRNA CTD PMID:29301061 , PMID:34032870 succimer multiple interactions ISO RGD:68500 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NR5A2 mRNA CTD PMID:26378955 sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of NR5A2 mRNA CTD PMID:25450479 sulpiride increases expression EXP 6480464 Sulpiride results in increased expression of NR5A2 mRNA CTD PMID:21427058 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NR5A2 mRNA more ... CTD PMID:21273442 , PMID:32741896 testosterone increases expression EXP 6480464 Testosterone results in increased expression of NR5A2 mRNA CTD PMID:21273442 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NR5A2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:68500 6480464 Carbon Tetrachloride results in decreased expression of NR5A2 mRNA CTD PMID:31919559 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of NR5A2 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:68500 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR5A2 mRNA CTD PMID:29950665 trichloroethene multiple interactions ISO RGD:68500 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of NR5A2 mRNA] CTD PMID:15363585 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NR5A2 mRNA CTD PMID:33387578 ursodeoxycholic acid increases expression ISO RGD:68500 6480464 Ursodeoxycholic Acid results in increased expression of NR5A2 mRNA CTD PMID:18687751 ursodeoxycholic acid multiple interactions ISO RGD:68500 6480464 NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of NR5A2 mRNA] CTD PMID:18687751 valproic acid increases expression ISO RGD:68499 6480464 Valproic Acid results in increased expression of NR5A2 mRNA CTD PMID:24935251 vancomycin multiple interactions ISO RGD:68500 6480464 [Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA CTD PMID:24657338 vincristine increases expression ISO RGD:68499 6480464 Vincristine results in increased expression of NR5A2 mRNA CTD PMID:23649840
